View Older Stories

Jan 22, 2026 05:05AM RBC Capital Upgrades Vertex (VRTX) to Outperform

Oct 12, 2025 03:00PM Biotech stocks: Q3 earnings preview

Oct 8, 2025 09:24AM Vertex (VRTX) PT Raised to $423 at RBC Capital

Aug 5, 2025 09:44AM Vertex (VRTX) PT Lowered to $405 at RBC Capital Amid Setbacks

Jun 17, 2025 10:14AM Vertex (VRTX) PT Lowered to $420 at RBC Capital

Jun 6, 2025 09:56AM RBC Capital weighs in on Vertex (VRTX) following IgAN competitor data

Apr 1, 2025 08:24AM Vertex (VRTX) PT Raised to $420 at RBC Capital; 'Alyftrek Could Be Off To a Good Start'

Feb 20, 2025 08:51AM Vertex (VRTX) PT Raised to $408 at RBC Capital

Jan 13, 2025 12:50PM RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA

Jan 7, 2025 09:15AM Vertex (VRTX) PT Raised to $401 at RBC Capital; 'We Would Look for a More Compelling Entry Point'

Nov 5, 2024 07:00AM Vertex (VRTX) PT Raised to $451 at RBC Capital

Oct 9, 2024 06:37AM Vertex (VRTX) PT Raised to $437 at RBC Capital

Jun 11, 2024 06:13AM Vertex (VRTX) PT Lowered to $421 at RBC Capital

May 7, 2024 06:21AM Vertex (VRTX) PT Raised to $424 at RBC Capital

Dec 1, 2021 03:31PM Vertex (VRTX) PT Raised to $265 at RBC Capital, Following Clinical Business Update

Apr 20, 2021 11:53AM CRISPR Therapeutics' (CRSP) Restructured Vertex (VRTX) Deal 'Fantastic', Analyst Says

Apr 16, 2021 06:34AM Vertex (VRTX) Risk/Reward Looks Attractive Heading into Potentially Imminent ’864 AAT Data - RBC Capital

Jan 21, 2021 06:32AM Vertex (VRTX) Site Data Indicates '864 Safety Could be Derisked in February - RBC Capital

Nov 30, 2020 06:11AM UPDATE: RBC Capital Upgrades Vertex (VRTX) to Outperform

Apr 28, 2020 05:12AM RBC Capital Downgrades Vertex (VRTX) to Sector Perform

Oct 31, 2019 06:39AM Vertex (VRTX) PT Raised to $235 at RBC Capital

Aug 16, 2019 10:51AM Vertex (VRTX) Clinicaltrials.gov Update Could Be Important For CF Life Cycle - RBC

Aug 1, 2019 06:20AM Vertex (VRTX) PT Raised to $213 at RBC Capital

May 1, 2019 07:23AM Vertex (VRTX) PT Lowered to $214 at RBC Capital

Feb 6, 2019 07:14AM Vertex (VRTX) PT Lowered to $213 at RBC Capital

Jan 3, 2019 03:59PM Bristol-Myers/Celgene Deal Likely Kicks Off 'Big Year' In Biopharma M&A - RBC

Oct 25, 2018 07:43AM Vertex (VRTX) PT Lowered to $204 at RBC Capital

Aug 17, 2018 01:32PM Vertex (VRTX) Gets Reimbursement in Australia - RBC

Jul 26, 2018 08:44AM Vertex (VRTX) PT Raised to $203 at RBC Capital

Jun 29, 2018 08:12AM Major Overhang Lifted for Vertex Pharma (VRTX) - RBC

May 15, 2018 07:56AM Vertex Pharma (VRTX), Alexion Pharma (ALXN) Least Impacted from Trump Drug Policies - RBC

Apr 27, 2018 09:01AM Vertex (VRTX) PT Raised to $202 at RBC Capital

Oct 18, 2017 06:19AM Vertex (VRTX) PT Raised to $181 at RBC Capital Citing Potential For Triple Early Approval

Sep 14, 2017 04:31PM RBC Capital Starts Vertex (VRTX) at Outperform

Aug 2, 2016 03:41PM Biogen (BIIB) Could Be Worth $375-475/Share in a Takeover - RBC Capital's Yee

Apr 4, 2016 01:52PM Biotech Seen Grinding Higher, Says RBC Capital (IBB)

Oct 23, 2015 08:34AM Vertex (VRTX) Seen as Top Large-Cap Biotech Growth Idea at RBC

Oct 12, 2015 07:57AM Vertex Pharma. (VRTX) Remains Top Pick at RBC Capital, Recommends Buying on Pullback

Sep 29, 2015 11:00AM Buyers Seem Like Deer-in-Headlights: RBC Capital; Analyst Comments on Biotech Rout

Sep 23, 2015 03:29PM Vertex (VRTX) Concerns Overdone, Buy Weakness - RBC Capital

Sep 23, 2015 03:28PM RBC Capital Defends Vertex Pharma (VRTX) Following Competition Speculation; Affirms at 'Outperform'

May 8, 2015 10:03AM RBC Comments on Vertex (VRTX) Following Orkambi Briefing Docs

Mar 30, 2015 09:55AM RBC Capital Comments on Vertex's (VRTX) FDA Meeting on '809 Combo

Mar 23, 2015 09:14AM Vertex (VRTX) Weakness Seen as Buying Opp at RBC Capital

Mar 5, 2015 08:57AM AbbVie (ABBV) /Pharmacyclics (PCYC) Deal Bullish for SMID Biotech and Big Drugs, Says RBC

Dec 30, 2014 12:40PM KALYDECO sNDA Approval is Another Incremental Positive for Vertex Pharma (VRTX) - RBC Capital

Nov 6, 2014 10:46AM Notable Analyst Rating Changes 11/6: (DATA) (MDLZ) (CMLP) Upgraded; (CDE) (DUK) (AEP) Downgraded

Oct 13, 2014 03:45PM RBC Capital Comments on Biotechs' Irish Tax Strategies; Gilead May See Modest EPS Impact (GILD) (AMGN)

Sep 26, 2014 03:11PM RBC Capital Comments on Recent Upside in Vertex (VRTX)

May 10, 2012 11:20AM Notable Analyst Rating Changes 05/10: (TPX) (PRU) (KERX) Upgraded; (VRTX) (HGSI) (ORCL) Downgraded

View Older Stories